• Tianjin Pharmaceutical Da Ren Tang Group held its ninth board meeting for fiscal 2026 on October 29, 2026.
• Directors approved third-quarter financial reports prepared under Chinese accounting standards and International Financial Reporting Standards.
• The board cleared a proposed new media promotion services agreement with Zhongjian Haoda Medical Supply Chain Management Service (Tianjin), an interested person transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tianjin Pharmaceutical Da Ren Tang Group Corporation Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: FYH196B6WAACAAC5) on October 30, 2026, and is solely responsible for the information contained therein.